Atlas Trials

A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer

Clinical trial NCT00064259 · TERMINATED

Trial details

NCT number
NCT00064259
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the StomachMixed Adenocarcinoma of the StomachRecurrent Esophageal CancerRecurrent Gastric CancerSquamous Cell Carcinoma of the EsophagusStage III Esophageal CancerStage IIIA Gastric CancerStage IIIB Gastric CancerStage IIIC Gastric Cancer
Start date
2003-06-01
Primary completion
2010-02-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.